CRIS
Curis Inc

13,588
Mkt Cap
$20.12M
Volume
0.00
52W High
$5.05
52W Low
$1.02
PE Ratio
-0.33
CRIS Fundamentals
50D MA
$1.65
Beta
0.91
Avg. Volume
70,076.19
EPS (Annual)
-$6.88
P/B
-1.23
Rev/Employee
$320,823.53
Loading...
Loading...
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
34

Frequently Asked Questions

What is Market Cap of Curis Inc?
What is the 52-week high for Curis Inc?
What is the 52-week low for Curis Inc?
What is the PE ratio of Curis Inc?
What is the Price-to-Book ratio of Curis Inc?
What is the 50-day moving average of Curis Inc?
How many employess does Curis Inc has?

Latest CRIS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.